Tocqueville Asset Management L.P. Purchases 1,343 Shares of Danaher Corporation $DHR

Key Points

• Tocqueville Asset Management L.P. increased its stake in Danaher Corporation by 2.9% in Q1, owning 47,181 shares worth approximately $9.67 million.
• Danaher recently reported earnings of $1.80 per share for the latest quarter, surpassing analyst expectations and showing a revenue increase of 3.4% year-over-year.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Danaher, with a target price averaging around $247.61, reflecting strong investor confidence.

Tocqueville Asset Management L.P. boosted its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 2.9% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 47,181 shares of the conglomerate's stock after acquiring an additional 1,343 shares during the period. Tocqueville Asset Management L.P.'s holdings in Danaher were worth $9,672,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of DHR. Vanguard Group Inc. grew its stake in Danaher by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 59,981,088 shares of the conglomerate's stock worth $12,296,123,000 after buying an additional 230,966 shares during the last quarter. Bank of New York Mellon Corp lifted its position in Danaher by 2.3% in the 1st quarter. Bank of New York Mellon Corp now owns 8,783,485 shares of the conglomerate's stock valued at $1,800,614,000 after purchasing an additional 194,466 shares during the last quarter. Northern Trust Corp boosted its stake in Danaher by 14.3% during the 4th quarter. Northern Trust Corp now owns 7,934,991 shares of the conglomerate's stock valued at $1,821,477,000 after purchasing an additional 992,594 shares during the period. Capital World Investors increased its stake in shares of Danaher by 32.7% in the fourth quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock valued at $1,460,215,000 after purchasing an additional 1,566,658 shares during the period. Finally, Capital Research Global Investors raised its holdings in shares of Danaher by 6.8% during the fourth quarter. Capital Research Global Investors now owns 5,812,728 shares of the conglomerate's stock valued at $1,334,312,000 after buying an additional 370,111 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Down 0.4%

Shares of NYSE DHR traded down $0.9530 during trading hours on Wednesday, hitting $211.2470. The stock had a trading volume of 3,302,498 shares, compared to its average volume of 4,235,380. The firm's 50-day moving average price is $200.33 and its two-hundred day moving average price is $199.54. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.90. The company has a market capitalization of $151.26 billion, a P/E ratio of 44.95, a P/E/G ratio of 2.92 and a beta of 0.73. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. During the same period in the previous year, the company earned $1.72 earnings per share. The company's revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of recent analyst reports. HSBC decreased their price objective on Danaher from $270.00 to $240.00 in a report on Friday, April 25th. Jefferies Financial Group lowered their price target on Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a research report on Tuesday, April 22nd. Evercore ISI cut their target price on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Royal Bank Of Canada reissued an "outperform" rating and issued a $250.00 price target on shares of Danaher in a research note on Wednesday, April 23rd. Finally, TD Cowen boosted their target price on shares of Danaher from $240.00 to $248.00 and gave the company a "buy" rating in a research note on Wednesday, April 23rd. Seventeen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $247.61.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.